Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain
A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test.
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 22; no. 4; pp. 1575 - 1578 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
15.02.2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.bmcl.2011.12.131 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2011.12.131 |